KALV
KalVista Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$16.94
-0.44 ▼ -2.53%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$16.94
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -4 | Insider Own | 26.41% | Shs Outstand | 0.05B | Perf Week | 4.37% |
| Market Cap | 0.86B | Forward P/E | 18.62 | EPS next Y | 300.74% | Insider Trans | -0.66% | Shs Float | 0.04B | Perf Month | 9.22% |
| Enterprise Value | 0.83B | PEG | - | EPS next Q | - | Inst Own | 111.83% | Short Float | 51.82% | Perf Quarter | 0.47% |
| Income | -0.20B | P/S | 598.78 | EPS this Y | 87.71% | Inst Trans | 11.73% | Short Ratio | 19.29 | Perf Half Y | 14.38% |
| Sales | 0.00B | P/B | 50.37 | EPS next 5Y | - | ROA | -97.71% | Short Interest | 19.28M | Perf YTD | 4.89% |
| Book/sh | 0.34 | P/C | 2.77 | EPS past 3/5Y | -3.17% -17.63% | ROE | -190.18% | 52W High | -10.84% ($19.00) | Perf Year | 38.29% |
| Cash/sh | 6.12 | P/FCF | - | Sales past 3/5Y | - | ROIC | -68.88% | 52W Low | 83.43% ($9.23) | Perf 3Y | 126.17% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -13.14% | Gross Margin | -9.33% | Volatility(W/M) | 8.83% 5.67% | Perf 5Y | -47.88% |
| Dividend TTM | - | EV/Sales | 580.19 | Sales Y/Y TTM | - | Oper. Margin | -14220.9% | ATR (14) | 1.01 | Perf 10Y | 77.94% |
| Dividend Ex-Date | - | Quick Ratio | 7.21 | EPS Q/Q | -1.45% | Profit Margin | -14242.57% | RSI (14) | 55.54 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.22 | Sales Q/Q | - | SMA20 | 4.25% ($16.25) | Beta | -0.31 | Target Price | $34 |
| Payout | - | Debt/Eq | 16.62 | Earnings | 2025/12/04 | SMA50 | 7.21% ($15.8) | Rel Volume | 0.84 | Prev Close | $17.38 |
| Employees | 270 | LT Debt/Eq | 16.34 | EPS/Sales Surpr. | 11.5% -100% | SMA200 | 21.15% ($13.98) | Avg Volume(3M) | 1.00M | Price | $16.94 |
| IPO | 2015/4/9 | Option/Short | Yes/Yes | Trades | 8912 | Volume | 844,241 | Change | -2.53% |
뉴스 로딩 중...